{
    "2020-09-07": [
        [
            {
                "time": "",
                "original_text": "凯莱英：3000万元收购冠勤医药100%股权",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "冠勤医药",
                        "收购",
                        "CRO公司",
                        "股权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)拟3000万元收购CRO公司冠勤医药100%股权",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "002821.SZ",
                        "冠勤医药",
                        "收购",
                        "CRO公司",
                        "股权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}